News Johnson & Johnson

Equities

JNJ

US4781601046

Real-time Estimate Cboe BZX Other stock markets 09:31:55 2024-04-16 am EDT			5-day change	1st Jan Change
145.2 ^USD	-1.63%		-2.64%	-5.84%

02:53pm	Johnson & Johnson Narrows Full-Year Outlook as First-Quarter Sales Miss Street Views	MT
01:40pm	Johnson & Johnson: EPS up to $2.20 in Q1	CF

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Johnson & Johnson Narrows Full-Year Outlook as First-Quarter Sales Miss Street Views	08:53am	MT
Johnson & Johnson: EPS up to $2.20 in Q1	07:40am	CF
Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug	07:20am	MT
Fed Outlook, Overseas Markets Cap Wall Street Pre-Bell; Asia, Europe Lower	07:15am	MT
Stock Futures Decline Pre-Bell as Traders Await More Earnings; Asia, Europe Down	07:12am	MT
Johnson & Johnson's Q1 Adjusted Earnings, Revenue Increase; 2024 Guidance Narrowed; Quarterly Dividend Lifted	07:12am	MT
Benylin Paediatric Syrup Banned	07:06am	AQ
Zimbabwe Issues Recall On Benylin Paediatric Syrup	07:06am	AQ
Johnson & Johnson 1Q Sales Rise on U.S. Growth, Cuts Adjusted EPS Outlook	07:01am	DJ
Johnson & Johnson Raises Quarterly Dividend by 4.2% to $1.24	06:49am	DJ
Johnson & Johnson : First Quarter 2024 1Q24 Other Financial Disclosures	06:41am	PU
Johnson & Johnson : 2024 First-Quarter Press Release & Supplemental Schedules	06:39am	PU
Earnings Flash (JNJ) JOHNSON & JOHNSON Posts Q1 Revenue $21.38B, vs. Street Est of $21.39B	06:30am	MT
Earnings Flash (JNJ) JOHNSON & JOHNSON Posts Q1 EPS $2.71, vs. Street Est of $2.65	06:28am	MT
North American Morning Briefing : Powell Comments, -2-	06:28am	DJ
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%	06:26am	BU
Johnson & Johnson Announces Quarterly Dividend, Payable on June 4, 2024	06:25am	CI
Johnson & Johnson Reports Q1 2024 Results	06:21am	BU
J&J beats first-quarter profit estimates on cancer drugs strength	06:20am	RE
Johnson & Johnson Reports Earnings Results for the First Quarter Ended March 31, 2024	06:20am	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST